reports
Moody's Ratings assigns Aa2 rating to preferred shares issued by Nuvee...
Rating Action: Moody's Ratings assigns Aa2 rating to preferred shares issued by Nuveen Municipal High Income Opportunity Fund following mergers. Global Credit Research- 27 Apr 2026. New York, April 27, 2026-- Moody's Ratings has assigned a long-term Aa2 rating to Series 1 Variable Rate Demand Preferred Shares issued by Nuveen Municipal High Income Opportunity Fund following the merger of three other Nuveen closed-end funds into the fund.
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (...
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026 DURHAM, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, April 28, 2026 at 8:00 AM ET featuring Prabir Roy-Chaudhury MD, PhD, FASN (University of North Carolina (UNC) Kidney Center, Salisbury VA Medical Center), and Mohamad A...
Humacyte Expands Commercial and Business Development Opportunities Thr...
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess® - Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius Medical Care - - Positions Humacyte to advance discussions with corporate partners regarding international and indication-specific rights to Symvess – - Existing terms related to U.S. distribution of Symvess remain unchanged DURHAM, N.C., April 24, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable...
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
Treace to Report First Quarter 2026 Financial Results on May 8, 2026 PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening...
Leggett & Platt Announces 1Q 2026 Earnings Release Date
Leggett & Platt Announces 1Q 2026 Earnings Release Date Carthage, MO, April 23, 2026 (GLOBE NEWSWIRE) -- Leggett & Platt (NYSE:LEG), a diversified manufacturer of engineered products serving several major markets, will release first quarter earnings results on Thursday, May 7, 2026 before the market opens. The Company will not host a call in connection with the earnings release. The earnings release will be available on the Investor Relations section of our website. COMPANY DESCRIPTION: Leggett & Platt (NYSE: LEG) is a diversified manufacturer that designs and produces a broad variet...
Norwegian Cruise Line Holdings to Hold Conference Call on First Quarte...
Norwegian Cruise Line Holdings to Hold Conference Call on First Quarter 2026 Financial Results MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced today it will report first quarter 2026 financial results on Monday, May 4, 2026 at 6:30 a.m. Eastern Time with a conference call and webcast to discuss results at 8:30 a.m. Eastern Time. The conference call will be webcast via the Company’s Investor Relations website, . A replay of the webcast will be availa...
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
Humacyte Appoints Jim Mercadante as Chief Commercial Officer – Industry veteran with more than 25 years of experience will lead next phase of biotech company’s commercial expansion – – Seasoned medtech commercial leader brings extensive field-specific success in vascular and cardiothoracic surgery markets – – Appointment strengthens commercial leadership as Symvess® (acellular tissue engineered vessel-tyod) market launch accelerates and pipeline advances toward planned BLA filing in dialysis – DURHAM, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-...
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing ...
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair - The Ministry of Health has set a 180-working-day review period for the MAA - - MAA process is one step in planned expansion of Symvess into multiple countries outside of the U.S - DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that its Marketing Authorization Applicati...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TTMI TTM TECHNOLOGIES INC.
MXL MAXLINEAR INC
MTRN MATERION CORPORATION
HXL HEXCEL CORPORATION
FORM FORMFACTOR INC.
AOSL ALPHA & OMEGA SEMICONDUCTOR
SILC SILICOM LTD.
ADS ALLIANCE DATA SYSTEMS CORPORATION
CACC CREDIT ACCEPTANCE CORPORATION
ELY CALLAWAY GOLF COMPANY
LEG LEGGETT & PLATT INCORPORATED
LIND LINDBLAD EXPEDITIONS HOLDINGS
AMKR AMKOR TECHNOLOGY INC.
VICR VICOR CORP.
STIM NEURONETICS
PAYS PAYSIGN INC
OPRT OPORTUN FINANCIAL
PSTL POSTAL REALTY TRUST
AFRM AFFIRM HOLDINGS
GFS GLOBALFOUNDRIES INC
GCT ONTO INNOVATION INC.
DAVE GIGACLOUD TECHNOLOGY INC
VIK DAVE INC
AEVA VIKING HOLDINGS LTD
AMBO AEVA TECHNOLOGIES INC.
LION AMBOW EDUCATION HLDG LTD
STRZ LIONSGATE STUDIOS CORP
INFO STARZ ENTERTAINMENT CORP
HPP HARBOR PANAGORA DYNAMIC LARGE CAP CORE ETF
HUDSON PACIFIC PROPERTIES L.P.
Moody's Ratings places Leggett & Platt's ratings under review for down...
Rating Action: Moody's Ratings places Leggett& Platt's ratings under review for downgrade. Global Credit Research- 14 Apr 2026. New York, April 14, 2026-- Moody's Ratings placed Leggett& Platt, Incorporated's ratings under review for downgrade, including the company's Baa3 senior unsecured rating, Baa3 unsecured MTN program rating, and Prime-3 commercial paper rating.
Treace Announces First Surgical Cases with the SuperBite™ Compression ...
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first cases utilizing its Supe...
Norwegian Cruise Line Holdings Announces Board Refreshment
Norwegian Cruise Line Holdings Announces Board Refreshment Appoints Five New Independent Members to the BoardEnters into Cooperation Agreement with Elliott MIAMI, March 27, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (the “Company” or “NCLH”) (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced the appointment of five highly qualified members to its Board of Directors and a cooperation agreement reached with Elliott Investment Management L.P. (together with its affiliates, "Elliott"...
Norwegian Cruise Line Holdings Enters into Employment and Equity Award...
Norwegian Cruise Line Holdings Enters into Employment and Equity Award Agreements with President and CEO MIAMI, March 27, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises (“NCLH” or the “Company”), announced that it has entered into an employment agreement and restricted share unit award agreement with John W. Chidsey, its President and Chief Executive Officer on March 26, 2026, in connection with his appointment. Mr. Chidsey was appointed as President...
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results ...
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia - - Submitted of a Marketing Authorization Application with the Israel Ministry of Health - - U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels - - Major milestone upcoming: T...
Humacyte Appoints Rick McElheny as Senior Vice President of Business D...
Humacyte Appoints Rick McElheny as Senior Vice President of Business Development - Mr. McElheney brings more than 15 of years’ experience in corporate development and alliance management at biopharma companies. - - He will work with the Company’s leadership team to expand corporate collaborations to accelerate the development and commercialization of Humacyte’s broad pipeline - DURHAM, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial sc...
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Result...
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026 DURHAM, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company will release its financial results for the quarter and year ended December 31, 2025 on Friday March 27, 2026. Management will host a webcast and conference call at 8:00 a.m. Eastern Time to provide a corporate and financial updat...
Humacyte Submits Marketing Authorization Application for Symvess® in I...
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair - Humacyte is also pursuing a mechanism for making Symvess available in Israel on a hospital-by-hospital basis in advance of MAA approval - - Preparation is underway for expansion of Symvess into other countries, including in the Middle East - DURHAM, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it submi...
- Jonathan Moreland
TBK TRIUMPH BANCORP INC.
MELI MERCADOLIBRE INC.
HTGC HERCULES CAPITAL INC.
AXTI AXT INC.
LFVN LIFEVANTAGE
HRI HERC HOLDINGS INC.
SXC SUNCOKE ENERGY INC.
CSWC CAPITAL SOUTHWEST CORP.
WINA WINMARK CORP.
AWI ARMSTRONG WORLD INDUSTRIES
PCB INC.
IDYA PACIFIC CITY FINANCIAL CORP
FOUR IDEAYA BIOSCIENCES
LRMR SHIFT4 PAYMENTS
PCVX INC.
ABCL LARIMAR THERAPEUTICS INC
ACVA VAXCYTE
TBBK ABCELLERA BIOLOGICS
FSCO ACV AUCTIONS INC.
ZURA THE BANCORP
NPWR INC.
EDSA FS CREDIT OPPORTUNITIES CORP.
LAW ZURA BIO LTD
NET POWER INC
EDESA BIOTECH INC
CS DISCO INC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.